← 返回

补骨脂素诱导肿瘤细胞和巨噬细胞焦亡并增强 NK 细胞细胞毒性以抑制肝细胞癌

英文原题:Psoralidin induces pyroptosis in both tumor cells and macrophages as well as enhances nature killer cell cytotoxicity to suppress hepatocellular carcinoma.

查看英文原题

Psoralidin induces pyroptosis in both tumor cells and macrophages as well as enhances nature killer cell cytotoxicity to suppress hepatocellular carcinoma.

PubMed 2025/06/05(内容时间) Mol Immunol Q2 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

补骨脂素是中药补骨脂的主要成分,补骨脂来源于豆科植物补骨脂的干燥成熟果实,具有多种药理作用,包括抗肿瘤作用。然而,补骨脂素保护肝细胞癌(HCC)的机制尚不清楚。在我们的研究中,我们发现补骨脂素诱导HepG2和Hepa1-6细胞发生焦亡和gasdermin E(GSDME)裂解,而caspase-3抑制剂Z-DEVD-FMK可逆转这一效应。

此外,补骨脂素诱导线粒体活性氧(ROS)产生,导致caspase-3激活并随后引起GSDME裂解。有趣的是,补骨脂素通过ROS-NLRP3炎症小体-gasdermin D(GSDMD)途径诱导巨噬细胞焦亡,导致白细胞介素(IL)-1β和IL-18分泌,从而促进自然杀伤(NK)细胞活化及其抗肿瘤能力。在小鼠模型中,补骨脂素抑制HCC生长,诱导肿瘤细胞焦亡,并增强T细胞和NK细胞的肿瘤浸润。

总之,我们的数据表明,补骨脂素通过ROS/caspase-3/GSDME诱导肿瘤细胞焦亡,并通过ROS/NLRP3炎症小体/GSDMD触发巨噬细胞焦亡,增强NK细胞抗肿瘤能力,提示补骨脂素可作为HCC的潜在治疗候选药物。

展开英文摘要原文

Psoralidin is a major component of the traditional Chinese medicine Psoraleae Fructus, which is derived from the dried mature fruit of the leguminous plant Psoralea corylifolia L. and possesses many pharmacological effects, including anti-tumor effects.

However, the mechanism through which psoralidin protects against hepatocellular carcinoma (HCC) remains unclear. In our study, we found that psoralidin induced pyroptosis and gasdermin E (GSDME) cleavage in HepG2 and Hepa1-6 cells, which were reversed by the caspase-3 inhibitor Z-DEVD-FMK.

Moreover, psoralidin induced mitochondrial reactive oxygen species (ROS) production, leading to caspase-3 activation and subsequent GSDME cleavage. Interestingly, psoralidin induced pyroptosis in macrophages via ROS-NLRP3 inflammasome-gasdermin D (GSDMD), leading to the secretion of interleukin (IL)-1β and IL-18, which promoted natural killer (NK) cell activation and its anti-tumor capability.

In a mouse model, psoralidin suppressed HCC growth, induced tumor cell pyroptosis, and enhanced tumor infiltration of T and NK cells. Collectively, our data demonstrate that psoralidin induces pyroptosis in tumor cells via ROS/caspase-3/GSDME and triggers pyroptosis in macrophages via ROS/NLRP3 inflammasome/GSDMD, enhancing NK cell anti-tumor ability, suggesting that psoralidin could be used as a potential therapeutic candidate for HCC.

论文信息

作者
Wang X、Xie Y、Yang H、Li C、Wen X、Chen S、Yao Q、Zheng C
第一作者单位
Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China; Military Institute of Chinese Materia, the Fifth Medical Centre, General Hospital of PLA, Beijing 100039, China.China
通讯作者单位
Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China; Military Institute of Chinese Materia, the Fifth Medical Centre, General Hospital of PLA, Beijing 100039, China; National Key Laboratory of Kidney Diseases, Beijing 100039, China. Electronic address: pharmacy_302@126.com.China
期刊
Molecular immunology2025 Aug
原文标识
PubMed 40479862 · DOI 10.1016/j.molimm.2025.05.020